Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of date. This is page number 20.

Order by Relevance | Date

Total 341 results found since Jan 2013.

National Mammography Day
Nearly 90% of women who find and treat their breast cancer are cancer-free at five years. Mammograms can help reduce the number of deaths from breast cancer among women ages 40 to 70. A mammogram is a low-dose x-ray picture of the breast. The US Food and Drug Administration (FDA) regulates the standards for mammography machines and training for the people who give mammograms. FDA also certifies the places that give mammograms in the U.S., under the Mammography Quality Standards Act (MQSA). FDA keeps a list of all certified places where you can get a mammogram.  For four mammography myths, along with helpful information y...
Source: BHIC - October 18, 2013 Category: Databases & Libraries Authors: Naomi Gonzales Tags: General Public Health Source Type: blogs

Harvard Stem Cell Institute publishes initial clinical trial results
Starting with a discovery within zebrafish in 2007, Harvard Stem Cell Institute (HSCI) researchers have published initial results of a Stage Ib human clinical trial of a therapeutic that has the potential to improve the achievements of blood stem cell transplantation. This marks the first time, just nine brief years after Harvard’s major dedication to stem cell biology, that will investigators have carried a breakthrough from the lab bench to the clinic—fulfilling the promise on which HSCI was founded. The particular Phase 1b safety study, published in the journal Bloodstream , included 12 adult individuals un...
Source: My Irritable Bowel Syndrome Story - October 8, 2013 Category: Other Conditions Authors: Ken Tags: IBS News Source Type: blogs

Dan Morain: When Big Pharma comes to town, drug costs tend to rise
Any time huge pharmaceutical companies descend on the Capitol, it’s a safe bet that patients are going to be paying more for the drugs they need.That’s the likely result if Gov. Jerry Brown signs Senate Bill 598, legislation dealing with the most costly life-saving drugs that biopharmaceutics use to treat the serious diseases: cancer, multiple sclerosis, HIV and the like.On its face, the bill by Sen. Jerry Hill, the San Mateo Democrat, is perfectly reasonable. It requires pharmacists to notify physicians if they substitute the biologic equivalent of generic drugs, known in the business as biosimilars.The notice is inte...
Source: PharmaGossip - September 30, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Takeda failed to adequately warn of Actos cancer risks, U.S. jury finds
WILMINGTON, DELAWARE – A Maryland jury has ruled that Takeda Pharmaceutical Co. failed to properly warn a former U.S. Army translator and his doctor about the risks of the firm’s Actos diabetes drug and ordered it to pay more than $1.7 million (¥168 million) in damages, but a judge immediately threw out the verdict, court documents show. Jurors in state court in Baltimore deliberated more than six hours over two days before finding Asia’s largest drugmaker liable for the death of Diep An from cancer, said one of the family’s lawyers, Michael Miller. Since jurors also found that An contributed to his death by smo...
Source: PharmaGossip - September 28, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

FDA Doesn't Want Public to Think that Cigarette Smoking is More Hazardous than Vaping
I hate to start another post with "Yes, you read that headline correctly," but indeed, you did read the headline correctly.The FDA has acknowledged that it does not want the public to think that cigarette smoking is any more hazardous than using a non-tobacco e-cigarette.According to an FDA spokeswoman, as quoted at WebMD: "We don't want the public to perceive them (e-cigarettes) as a safer alternative to cigarettes."The Rest of the StoryWhy in the world does the FDA want the public to think that cigarette smoking is no more hazardous than vaping?Even the tobacco industry, in 2013, acknowledges that smoking is more harmful...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - September 19, 2013 Category: Health Medicine and Bioethics Commentators Source Type: blogs

Fighting the injustice of health disparities: Honoring the legacies of Dr. Martin Luther King Jr. and Dr. John M. Eisenberg
For the past several years I have run this post and just as it was those years, it is this year a very important message. We, as a nation, have made progress and I believe Dr. King would be proud. But our work is far from complete – particularly where health care is concerned. Another doctor, Dr. John M. Eisenberg, a physician of tremendous stature whose life was also tragically cut short (not by an assassin’s bullet but by brain cancer) was equally passionate about the dignity of life and justice for all Americans. Dr. Eisenberg, who among other things, served as the Director of the Agency for Health Care Policy and R...
Source: Disruptive Women in Health Care - August 28, 2013 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Advocacy Health Reform Policy Politics Publc Health Source Type: blogs

Healthcare group Fresenius warned over Puerto Rico plant
Aug 23 (Reuters) - U.S. regulators have issued a third warning this year for German healthcare group Fresenius to improve procedures at its sites, this time a blood bag manufacturing plant in Puerto Rico. A letter to the company from the U.S. Food and Drug Administration (FDA) took issue with complaint-handling procedures and labelling at the Puerto Rico site, the German company said on Friday, adding that patients had not been put at risk. Fresenius said that it is addressing the concerns raised by the FDA and that production at the plant is continuing, adding that full-year earnings targets for the infusion drugs and b...
Source: PharmaGossip - August 24, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

A Guide to Cervical Cancer Screening & HPV Vaccines
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the United States. According to the Centers for Disease Control and Prevention (CDC), “nearly all sexually-active men and women will get at least one type of HPV at some point in their lives.” But the virus usually clears on its own, without causing any damage — and often without showing any symptoms. The HPV vaccine can prevent infection, but it’s not for everyone. We’ll tell you what you need to know about the virus and the vaccine. What are the risks from HPV? In both men and women, HPV infection can lead to warts or ...
Source: Our Bodies Our Blog - August 16, 2013 Category: Health Medicine and Bioethics Commentators Authors: Rachel Tags: Activism & Resources STIs Source Type: blogs

Purdue Pharma has privately identified about 1,800 doctors who may have recklessly prescribed the painkiller to addicts and dealers, yet it has done little to alert authorities.
By Scott Glover and Lisa Girion August 11, 2013, 7:00 a.m. Over the last decade, the maker of the potent painkiller OxyContin has compiled a database of hundreds of doctors suspected of recklessly prescribing its pills to addicts and drug dealers, but has done little to alert law enforcement or medical authorities. Despite its suspicions, Purdue Pharma continued to profit from prescriptions written by these physicians, many of whom were prolific prescribers of OxyContin. The company has sold more than $27 billion worth of the drug since its introduction in 1996. Purdue has promoted the idea that the country's epidemic of...
Source: PharmaGossip - August 12, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

The FDA - a little background
We all love to hate the FDA. I mean they are the people that take food off the market, have all these rules and things that make food cost more, delay the acceptance of new medications, and cause pharmaceutical companies to have all these years of research driving up their 'costs' (which get paid by patients in the end, one way the other). So why do we have an FDA? How did that happen? I never really knew or thought much about it. I just thought it was another one of those big Washington based alphabet agencies making rules and spending the public's money. I try to assume that people are going to do the right thing and not...
Source: Caroline's Breast Cancer Blog - August 2, 2013 Category: Cancer Tags: safety medication food Source Type: blogs

Fighting Cancer May Be Harder As Many Drug Trials Are Undisclosed
To disclose or not to disclose? Shakespearean allusions aside, there is little question that drugmakers and researchers are under increasing pressure to comply with demands to publicly disclose clinical trial results. The failure to do so, of course, raises concerns that undisclosed results can lead to biased medical literature, especially in meta-analyses, and inappropriate treatment decisions. Now, another study finds that clinical trial results have been kept under wraps. The latest evidence appears in the Journal of Clinical Oncology and reports that nearly half of cancer drug trials reviewed had no results publicly av...
Source: Pharmalot - July 30, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs

FDA Proposed Rule Expedited Programs for Serious Conditions – Drugs and Biologics
Recently, the Food and Drug Administration (FDA) released a Guidance for Industry, entitled "Expedited Programs for Serious Conditions—Drugs and Biologics." The draft guidance provides a single resource for information on FDA's policies and procedures for four programs intended to facilitate and expedite development and review of new drugs to address unmet medical need in the treatment of a serious or life threatening condition: 1) fast track designation; 2) breakthrough therapy designation; 3) accelerated approval; and 4) priority review designation. This guidance also outlines the threshold criteria ...
Source: Policy and Medicine - July 24, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs

More on Sweeteners: Aspartame
By Amy Campbell Once again, I'd like to thank everyone for their commentary, feedback, and questions regarding the two sweeteners I've recently written about: Splenda and Nectresse. Due to popular demand, I've decided to extend my series and focus this week on another standby, aspartame. Aspartame Aspartame is one of the older nonnutritive sweeteners, having been discovered in 1965. However, it has only been used in the US since the 1980's. Sold under the brand names Equal and NutraSweet, It's also one of the most commonly used sweeteners. Its patent expired in 1992, so generic versions of aspartame are now sold as well. T...
Source: Diabetes Self-Management - July 22, 2013 Category: Diabetes Authors: Amy Campbell Source Type: blogs

Healthcare in China: GSK claims prompt crackdown on corruption
Chinese state health insurance subsidises treatments up to a ceiling, after which the patient must pay the difference. Photograph: AFPOn a summer day about a month before Chinese authorities revealed explosive bribery allegations against the British drug-makerGlaxoSmithKline (GSK), a woman in south-western Guizhou province walked into a hospital with her husband. After a routine gynaecological exam, doctors prescribed her £20 worth of Chinese medicine, some with controversial ingredients. The woman and her husband demurred, but – at the doctor's insistence– ultimately handed over the cash."There were a lot of peo...
Source: PharmaGossip - July 21, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs

Do Clinical Trials Work? - NYT
EVERY spring, some 30,000 oncologists, medical researchers and marketers gather in an American city to showcase the latest advances in cancer treatment.But at the annual meeting of the American Society of Clinical Oncology last month, much of the buzz surrounded a study that was anything but a breakthrough. To a packed and whisper-quiet room at the McCormick Place convention center in Chicago, Mark R. Gilbert, a professor of neuro-oncology at the University of Texas M. D. Anderson Cancer Center in Houston, presented the results of a clinical trial testing the drug Avastin in patients newly diagnosed with glioblastoma multi...
Source: PharmaGossip - July 15, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs